MEC Basic – MyMedflix Member Portal

New Therapeutic Directions in Lung Cancer

New Therapeutic Directions in Lung Cancer

Surbhi Singhal, MD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

Nicholas Mitsiades, MD, PhD

Recent Advances in Breast Cancer

Recent Advances in Breast Cancer

Mili Arora, MD

ALL REVOLUTION: Improving Outcomes for ALL

ALL REVOLUTION: Improving Outcomes for ALL

Wendy Stock, MD

New Developments in Thrombosis Management in Cancer

New Developments in Thrombosis Management in Cancer

Anjlee Mahajan, MD

Recent Advances in Acute Leukemias

Recent Advances in Acute Leukemias

Brian A. Jonas, MD, PhD, FACP

Recent Updates in Multiple Myeloma

Recent Updates in Multiple Myeloma

Aaron Rosenberg, MD, MS

State of the Art in Non-Hodgkin Lymphoma

State of the Art in Non-Hodgkin Lymphoma

Joseph Tuscano, MD

Update on Sickle Cell Anemia and Hemoglobinopathies

Update on Sickle Cell Anemia and Hemoglobinopathies

Oyebimpe Adesina, MD, MS

Growing UP! Progress in Treatment of Young Adults with ALL

Growing UP! Progress in Treatment of Young Adults with ALL

Wendy Stock, MD

Empowering Research with Excelling and Expanding Pharmacy Services

Empowering Research with Excelling and Expanding Pharmacy Services

Vivian H. Nguyen, PharmD, BCPS

Establishment of a Biosimilar Economic Dashboard to Inform Organizational Strategy

Establishment of a Biosimilar Economic Dashboard to Inform Organizational Strategy

Halena Leah Marcelin, PharmD, MS, CPh, 340B ACE

Oncology Pharmacy Training; A Discussion with Kelley Carlstrom

Oncology Pharmacy Training; A Discussion with Kelley Carlstrom

Kelley D. Carlstrom, PharmD, BCOP

Two for the Price of One: Review of Bispecific Antibodies in Lymphoma and Myeloma

Two for the Price of One: Review of Bispecific Antibodies in Lymphoma and Myeloma

Claudia Martin Diaz, PharmD, BCPS, BCOP

Novel IntraVesical Therapies | Transition from Clinical Operations to Operational Considerations

Novel IntraVesical Therapies | Transition from Clinical Operations to Operational Considerations

Alga Ramos Morales, PharmD, MS, MBA, BCPS, BCOP, CSSGB

$When the CARs Crash, What is Next? A Review of Relapsed / Refractory Treatment Options in DLBCL$

When the CARs Crash, What is Next? A Review of Relapsed / Refractory Treatment Options in DLBCL

Audra Andersen, PharmD, BCOP & Leonette Kemp, PharmD, CPE, BCOP

New Frontiers in Breast Oncology

New Frontiers in Breast Oncology

Diana Van Ostran, PharmD, BCOP

Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer

Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer

Khurrum Qureshi, PharmD, BCOP

Clinical and Practice Considerations in the Management of Iron Deficiency Anemia with IV Infusion

Clinical and Practice Considerations in the Management of Iron Deficiency Anemia with IV Infusion

Jorge Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE

Billing for Pharmacist Services in Oncology Setting

Billing for Pharmacist Services in Oncology Setting

Anay Moscu, PharmD, BCPS, BCOP, ACRP-CP

$Advancement in Therapy Options for BCG-Refractory Patients$

Advancement in Therapy Options for BCG-Refractory Patients

Mayret Gonzalez, PharmD, BCPS, BCOP

Target Therapy Updates

Target Therapy Updates

Jonathan W. Riess, MD

Immunotherapy Updates in Lung Cancer

Immunotherapy Updates in Lung Cancer

Zhaohui (Ann) Arter, MD

Localized Breast Cancer Updates

Localized Breast Cancer Updates

Helen Chew, MD

Metastatic ER Positive Breast Cancer Updates in 2024

Metastatic ER Positive Breast Cancer Updates in 2024

Sayeh Lavasani, MD

Metastatic HER2 Positive Breast Cancer Updates in 2024

Metastatic HER2 Positive Breast Cancer Updates in 2024

Mark D. Pegram, MD

Nuclear Medicine Updates

Nuclear Medicine Updates

Shyam Srinivas, MD

Prostate Cancer Updates

Prostate Cancer Updates

Arash Rezazadeh Kalebasty, MD

Radiation Oncology GU Updates

Radiation Oncology GU Updates

Steven Seyedin, MD

Urology Updates from AUA Meeting

Urology Updates from AUA Meeting

Michael A. Daneshvar, MD